NCT06714318 SMARTER: Using Blood Samples to iMprove FIT-bAsed coloRecTal cancEr scReening
| NCT ID | NCT06714318 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vejle Hospital |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-12-02 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-12-02 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project aims to investigate whether colorectal cancer screening can be improved using blood tests, thereby reducing the number of unnecessary colonoscopies. The Danish colorectal cancer screening program was implemented in 2014, and currently, all individuals aged 50-74 are invited every two years to participate. Those who test positive for hidden blood in their stool are referred for a colonoscopy. More than a third of the approximately 25,000 colonoscopies performed annually in the screening program can be classified as unnecessary, as they reveal a normal colon. This results in avoidable and unpleasant procedures for individuals and strains healthcare resources. The project seeks to reduce the number of these unnecessary colonoscopies by investigating whether blood biomarkers can identify individuals at very low risk of colorectal cancer after a positive stool test for hidden blood. By utilizing blood tests, screening could become more personalized, precise, and resource-efficient for the healthcare system.
Eligibility Criteria
Inclusion Criteria: * Participation in the colorectal cancer screening program. Exclusion Criteria: * Participants are excluded if a colonoscopy is not completed unless this is due to a colorectal cancer obstruction.
Contact & Investigator
Jonna Skov Madsen, Prof., MD
STUDY CHAIR
Biochemistry and Immunology, Lillebaelt Hospital
Frequently Asked Questions
Who can join the NCT06714318 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 74 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06714318 currently recruiting?
Yes, NCT06714318 is actively recruiting participants. Contact the research team at line.haugaard.fly@rsyd.dk for enrollment information.
Where is the NCT06714318 trial being conducted?
This trial is being conducted at Aabenraa, Denmark, Vejle, Denmark.
Who is sponsoring the NCT06714318 clinical trial?
NCT06714318 is sponsored by Vejle Hospital. The principal investigator is Jonna Skov Madsen, Prof., MD at Biochemistry and Immunology, Lillebaelt Hospital. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.